Skip to content

13F-HR filed by Bruce & Co., Inc.

Bruce & Co., Inc. filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-16, with 31 holding rows worth $500,144,000.

Accession
0001104659-22-024272
Filed
2022-02-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2021

A holdings report, 31 entries on the cover page, a total value of $500,144,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $500,144,000 with VALUE read as thousands by filing date, 13F file number 028-11869. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
U HAUL HOLDING COMPANY023586100COM75,355$54,725,000thousands by filing date
Nextera Energy302571104Common490,400$45,783,000thousands by filing date
AbbVie,Inc.00287Y109COM303,500$41,093,000thousands by filing date
VALEANT PHARMACEUTICALS INTL91911K102COM1,381,000$38,129,000thousands by filing date
ALLSTATE CORP COM020002101Stock299,300$35,212,000thousands by filing date
Pfizer Inc.717081103COM543,700$32,105,000thousands by filing date
CMS ENERGY CORP COM125896100Stock468,500$30,475,000thousands by filing date
Duke Energy Corporation26441C204COM286,200$30,022,000thousands by filing date
Apple Inc037833100COM167,400$29,725,000thousands by filing date
XCELENERGY INC98389B100COM412,500$27,926,000thousands by filing date
Abbott Laboratories002824100COM177,600$24,995,000thousands by filing date
MERCK &COINC589331107COM323,700$24,808,000thousands by filing date
Paratek699374AA2Cv 4.75%16,600,000$15,272,000thousands by filing dateprincipal
SUPERNUS PHARMACEUTICALS868459108COM402,105$11,725,000thousands by filing date
GENERAL ELEC CO369604103COM104,375$9,860,000thousands by filing date
AVISTA CORP COM05379B107Stock205,000$8,710,000thousands by filing date
PARATEK PHARMACEUTICALS INC699374302Equity1,443,312$6,480,000thousands by filing date
SIRIUS XM HOLDINGS INC82968B103COM857,843$5,447,000thousands by filing date
Acorda Theraputics00484MAB2Cv 6.0%5,000,000$4,075,000thousands by filing dateprincipal
NEWMONT CORP651639106COM65,000$4,031,000thousands by filing date
AMRYT PHARMA LTD - SPNR ADR03217L106COMMON EQUITY315,182$3,403,000thousands by filing date
EDAP TMS S A268311107SPONSORED ADR565,652$3,388,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM57,000$3,335,000thousands by filing date
Ashland044209104Common25,000$2,691,000thousands by filing date
MANNKIND CORP COM NEW56400P706Stock395,073$1,726,000thousands by filing date
IGM BIOSCIENCES INC449585108COM55,000$1,613,000thousands by filing date
ORGANON & CO COMMON STOCK68622V106Stock32,370$985,000thousands by filing date
VIATRIS INC COM92556V106Stock61,512$832,000thousands by filing date
NOVAVAX INC670002AB0NOTE 3.750% 2/0600,000$828,000thousands by filing dateprincipal
FLOTEK INDS INC DEL343389102COM421,671$476,000thousands by filing date
RLI CORP COM749607107Stock2,400$269,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-22-024272this filing2022-02-16acceptance time not in the bulk data set